Recalls / Active ingredient / Terlipressin
Terlipressin
1 FDA drug recall involving the active ingredient “Terlipressin”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-02-06 | Class II | Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Ho | Mallinckrodt Hospital Products Inc. |